Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCD Symptoms and Tobacco Dependence
NCT03651869Phase 1Completed
- Sponsor
- University of Southern California
- Start
- Feb 2019
- Primary completion
- Mar 2023
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of nicotine patch in tobacco dependence, sponsored by University of Southern California. Primary endpoint: Smoking Urge at 2 weeks. Started Feb 2019; status: completed.
02
Drugs
nicotine patch
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT03651869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03651869.